Replies to post #399484 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

I think it’s too bad the rule is not enforced.

100% agree
Other than me (ore perhaps other shareholders Im not aware of) emailing the NIH about the study completion date (yes ex I emailed them happy now?), the NIH is not even aware of NWBO's study completion date for NWBO has not provided that info. Now, why is that?

[CherryTree1]

I am all for sharing information as soon as possible in a perfect world, but as you have seen there are forces at play that don't want to play fair and would like nothing better than to see NWBO fail so they can pick up the technology for a song and either take it forward themselves or lock it up so they can continue to make windfall profits off the current chemo drugs.
https://www.statista.com/chart/18311/sales-revenues-of-drug-classes/

According to Evaluate's calculations, oncology drugs reached $145.4 billion in sales in 2019, almost triple that of the next item on the list, drugs treating diabetes with $51 billion dollars in sales. By 2026, cancer drug sales are expected to more than double their sales to $311.2 billion.

One thing for sure when there is this much money in play the players are not going to simply fold their cards in a polite gentlemanly manner and concede.

In fairness to NWBO they have released results the like still blinded data journal article when the felt the could do it in a way that didn't expose them to frivolous lawsuits and manipulation.
GLTU